D
D. Max Parkin
Researcher at University of Oxford
Publications - 19
Citations - 5354
D. Max Parkin is an academic researcher from University of Oxford. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 15, co-authored 19 publications receiving 4622 citations. Previous affiliations of D. Max Parkin include Queen Mary University of London & Clinical Trial Service Unit.
Papers
More filters
Journal ArticleDOI
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
Wendy Atkin,Rob Edwards,Ines Kralj-Hans,Kate Wooldrage,Andrew Hart,J. M. A. Northover,D. Max Parkin,Jane Wardle,Stephen W. Duffy,Jack Cuzick +9 more
TL;DR: Flexible sigmoidoscopy is a safe and practical test and, when offered only once between ages 55 and 64 years, confers a substantial and longlasting benefit.
Journal ArticleDOI
International lung cancer trends by histologic type: Male:female differences diminishing and adenocarcinoma rates rising
TL;DR: Rates of all lung cancer types among women and adenocarcinoma among men continue to rise despite declining cigarette use in many Western countries and shifts to filtered/low‐tar cigarettes.
Journal ArticleDOI
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
Melina Arnold,Mark J. Rutherford,Mark J. Rutherford,Aude Bardot,Jacques Ferlay,Therese M.-L. Andersson,Tor Åge Myklebust,Hanna E. Tervonen,Vicky Thursfield,David Ransom,Lorraine Shack,Ryan Woods,Donna Turner,Suzanne Leonfellner,S Ryan,Nathalie Saint-Jacques,Prithwish De,Carol McClure,Agnihotram V. Ramanakumar,H Stuart-Panko,Gerda Engholm,Paul M. Walsh,Christopher Jackson,Sally Vernon,Eileen Morgan,Anna Gavin,David S. Morrison,Dyfed Wyn Huws,Geoff Porter,John Butler,Heather Bryant,David C. Currow,Sara Hiom,D. Max Parkin,Peter Sasieni,Paul C. Lambert,Paul C. Lambert,Bjørn Møller,Isabelle Soerjomataram,Freddie Bray +39 more
TL;DR: Progress in cancer control over the study period was evident for stomach, colon, lung (in males), and ovarian cancer, and the impact of comorbidity are likely the main determinants of patient outcomes.
Journal ArticleDOI
Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness
Freddie Bray,D. Max Parkin +1 more
TL;DR: An update of the practical aspects and techniques for addressing data quality at the cancer registry is provided, namely, the comparability, validity and timeliness of cancer registry data.
Journal ArticleDOI
Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness.
D. Max Parkin,Freddie Bray +1 more
TL;DR: This second instalment of a two-part review of data quality methods at the cancer registry focuses on the principles and techniques available for estimating completeness, separating methods into those that are semi-quantitative -- in that they give an indication of the degree of completeness relative to other registries or over time, and more quantitative techniques -- those that provide a numerical evaluation.